| Peter B Sinks, MD | |
|
1505 Daphne Ave, Daphne, AL 36526-4298 | |
| (251) 625-2663 | |
| (251) 625-3198 |
| Full Name | Peter B Sinks |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Rheumatology |
| Location | 1505 Daphne Ave, Daphne, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316989262 | NPI | - | NPPES |
| 009937762 | Medicaid | AL | |
| 271325000 | Medicaid | FL | |
| 51535658 | Other | AL | BLUE CROSS |
| 09278248 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 27323 (Alabama) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | 27323 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Peter B Sinks, MD 1505 Daphne Ave, Daphne, AL 36526-4298 Ph: (251) 625-2663 | Peter B Sinks, MD 1505 Daphne Ave, Daphne, AL 36526-4298 Ph: (251) 625-2663 |
News Archive
Adding quinoa to the gluten-free diet of patients with celiac disease is well-tolerated, and does not exacerbate the condition, according to new research published in The American Journal of Gastroenterology. Dr. Victor F. Zevallos, from the Department of Gastroenterology, King's College London, United Kingdom, evaluated the in-vivo effects of consuming quinoa in adult celiac patients. Quinoa, a highly nutritious grain, is traditionally recommended as part of a gluten-free diet.
In response to the growing problem of drinking water contaminated with per- and poly-fluoroalkyl substances, a new analysis shows that many states are establishing their own guideline levels for two types of PFAS-PFOA and PFOS-that differ from federal guidelines.
Alkermes plc today announced the initiation of a phase 3 clinical trial of ALKS 9070 for the treatment of schizophrenia. ALKS 9070, a proprietary Alkermes molecule, is designed to provide patients with once-monthly dosing of a medication that, once in the body, converts into aripiprazole, a molecule that is commercially available under the name ABILIFY for the treatment of a number of central nervous system disorders.
A Texas A&M University biologist has received a federal grant to study the fecal samples of hundreds of people to better understand the gut bacteria Clostridium difficile - the cause of some 14,000 deaths a year in America - and to help lay the basic science foundation to develop drugs to combat its deadly results.
› Verified 2 days ago
Brittany Holley Case, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 29653 Anchor Cross Blvd, Daphne, AL 36526 Phone: 251-625-6896 Fax: 251-625-6897 | |
Dr. William Larry Davidson Ii, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 8725 County Road 64, Daphne, AL 36526 Phone: 251-625-1370 Fax: 251-625-1380 | |
Dr. George M Mccullars, M.D., PH.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 1 Timber Way Ste 202, Daphne, AL 36527 Phone: 251-342-1808 Fax: 251-342-1838 | |
William Curry Mcevoy, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 29653 Anchor Cross Blvd, Daphne, AL 36526 Phone: 251-625-6896 | |
Donato G Dumlao, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 29653 Anchor Cross Blvd, Daphne, AL 36526 Phone: 251-625-6896 Fax: 251-625-6897 |